INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE TERMINATION AGREEMENTIntellectual Property Assignment and License Termination Agreement • March 10th, 2009 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This Intellectual Property Assignment and License Termination Agreement (the “Agreement”), effective as of March 6, 2009 (“Effective Date”), is by and between SARcode Corporation, a Delaware corporation having its principal place of business at 343 Sansome Street, Suite 505, San Francisco, CA 94104 (“SARcode”), and Sunesis Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 395 Oyster Point Boulevard, Suite 400, South San Francisco, CA 94080 (“Sunesis”).
